COWA LLC’s AstraZeneca AZN Stock Holding History

COWA LLC’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$243K	Sell	1,234 -1	-0.1%	-$193	0.07%	141
2025 Q4	$227K	Buy	+1,235	New	+$217K	0.07%	144
2024 Q1	–	Sell	-1,600	Closed	-$216K	–	121
2023 Q4	$216K	Sell	1,600 -2,000	-56%	-$260K	0.13%	106
2023 Q3	$488K	Sell	3,600 -690	-16%	-$94.2K	0.33%	57
2023 Q2	$614K	Sell	4,290 -17,278	-80%	-$2.54M	0.4%	54
2023 Q1	$575K	Buy	21,568 +17,218	+396%	+$2.32M	0.47%	53
2022 Q4	$636K	Sell	4,350 -510	-10%	-$64K	0.4%	55
2022 Q3	$534K	Buy	4,860 +550	+13%	+$69.8K	0.35%	61
2022 Q2	$569K	Hold	4,310	–	–	0.33%	68
2022 Q1	$572K	Hold	4,310	–	–	0.28%	69
2021 Q4	$502K	Buy	4,310 +50	+1%	+$5.88K	0.25%	71
2021 Q3	$512K	Sell	4,260 -225	-5%	-$26.2K	0.29%	67
2021 Q2	$541K	Buy	4,485 +210	+5%	+$23K	0.34%	56
2021 Q1	$427K	Buy	4,275 +580	+16%	+$58.3K	0.26%	68
2020 Q4	$375K	Buy	+3,695	New	+$391K	0.29%	68

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

COWA LLC's AZN Position: Q1 2026 in Review

COWA LLC reduced its AstraZeneca (AZN) stake by 0.08% in Q1 2026, selling an estimated $193 and leaving 1,234 shares worth $243K. The position accounts for 0.07% of the portfolio, ranked #141.

COWA LLC first reported a position in AZN in Q4 2020 and has held it in 15 quarters since. The position peaked at $636K in Q4 2022. 1,379 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

COWA LLC held 1,234 shares of AstraZeneca worth $243K as of Q1 2026.
COWA LLC sold 1 AstraZeneca share in Q1 2026, an estimated $193.
AstraZeneca made up 0.07% of COWA LLC's portfolio in Q1 2026, its #141 holding.
COWA LLC first reported a position in AstraZeneca in Q4 2020 and has held it in 15 quarters since.
COWA LLC's AstraZeneca position peaked at $636K in Q4 2022.
1,379 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on COWA LLC's 13F filing for Q1 2026, filed 14 May 2026.